HL Financial Services’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $211K | Buy |
6,988
+475
| +7% | +$14.3K | ﹤0.01% | 695 |
|
|
2018
Q4 | $219K | Sell |
6,513
-2,298
| -26% | -$77.3K | ﹤0.01% | 672 |
|
|
2018
Q3 | $372K | Buy |
8,811
+911
| +12% | +$38.5K | 0.01% | 594 |
|
|
2018
Q2 | $253K | Buy |
7,900
+2,071
| +36% | +$66.3K | ﹤0.01% | 624 |
|
|
2018
Q1 | $290K | Buy |
5,829
+115
| +2% | +$5.72K | 0.01% | 589 |
|
|
2017
Q4 | $308K | Buy |
5,714
+821
| +17% | +$44.3K | 0.01% | 505 |
|
|
2017
Q3 | $284K | Buy |
4,893
+178
| +4% | +$10.3K | 0.01% | 586 |
|
|
2017
Q2 | $233K | Sell |
4,715
-47,278
| -91% | -$2.34M | ﹤0.01% | 628 |
|
|
2017
Q1 | $2.26M | Sell |
51,993
-1,939
| -4% | -$84.2K | 0.05% | 225 |
|
|
2016
Q4 | $2.64M | Sell |
53,932
-3,619
| -6% | -$177K | 0.06% | 201 |
|
|
2016
Q3 | $2.75M | Buy |
57,551
+10,920
| +23% | +$523K | 0.06% | 187 |
|
|
2016
Q2 | $2.5M | Buy |
46,631
+4,283
| +10% | +$230K | 0.06% | 180 |
|
|
2016
Q1 | $1.89M | Buy |
42,348
+7,945
| +23% | +$355K | 0.05% | 216 |
|
|
2015
Q4 | $1.31M | Buy |
34,403
+8,131
| +31% | +$310K | 0.03% | 270 |
|
|
2015
Q3 | $836K | Buy |
26,272
+374
| +1% | +$11.9K | 0.02% | 309 |
|
|
2015
Q2 | $855K | Buy |
25,898
+7,286
| +39% | +$241K | 0.02% | 343 |
|
|
2015
Q1 | $766K | Buy |
18,612
+4,276
| +30% | +$176K | 0.02% | 359 |
|
|
2014
Q4 | $584K | Buy |
+14,336
| New | +$584K | 0.02% | 393 |
|